Rebenku István

1.

Kemenes, G., Rebenku, I., Bajdik, B., Vereb, G., Takács, L.: Correlation of Multimodal Clinical Imaging With the Whole-Slide- and Superresolution-Based Immunohistological Structure of the Corneal Limbal Stroma.
Invest. Ophthalmol. Vis. Sci. 66 (9), 1-13, (article identifier: 54), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Cellular and Molecular Neuroscience (2024)

Q1 Ophthalmology (2024)

Q1 Sensory Systems (2024)

2.

Kemenes, G., Rebenku, I., Vereb, G., Takács, L.: Developing an ex vivo human cornea model for discovering the cellular interactions in simple limbal epithelial transplantation.
Invest. Ophthalmol. Vis. Sci. 66 (8), 1042, 2025.

DEA

3.

Hajdu, T., Rebenku, I., Cano, T. G. S., Mocsár, G., Bécsi, B., Erdődi, F., Nagy, P.: Fluorescence labeling-induced structural rearrangement of a monoclonal IgG revealed by biophysical experiments and simulations.
Int. J. Biol. Macromol. 321, 1-45, (article identifier: 146209), 2025.

doi DEA Scopus

Journal metrics:

Q1 Biochemistry (2024)

Q1 Biomaterials (2024)

D1 Food Science (2024)

Q2 Molecular Biology (2024)

Q2 Structural Biology (2024)

4.

Nagyné Szabó, Á. T., Tóth, G., Szatmári, T., Mocsár, G., Rebenku, I., Szöllősi, J., Nagy, P.: Local ligand concentration gradients induced by the plasma membrane.
iScience. 28 (7), 1-12, (article identifier: 112954), 2025.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary (2024)

5.

Horváth, D., Pénzes, Z., Molnár, P., Rebenku, I., Vereb, G., Szántó, M., Muzsai, S., Szegedi, A., Dajnoki, Z., Pázmándi, K. L., Fekete, T., Bácsi, A., Szöllősi, A. G.: Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype.
Front. Immunol. 16, 1-14, (article identifier: 1593141), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology (2024)

Q1 Immunology and Allergy (2024)

6.

Gergely, B., Vereb, M. A., Rebenku, I., Vereb, G., Szöőr, Á.: Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.
Cancers. 17 (5), 1-17, (article identifier: 731), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research (2024)

Q1 Oncology (2024)

7.

Nagy, L., Mezősi-Csaplár, M., Rebenku, I., Vereb, G., Szöőr, Á.: Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15, 1-38, (article identifier: 1365172), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology

Q1 Immunology and Allergy

8.

Takács, L., Kemenes, G., Bajdik, B., Fodor, M., Rebenku, I., Vereb, G.: Examination of limbal stromal structures by in vivo confocal microscopy and anterior segment optical coherence tomography angiography: correlation with immunohistological analysis of limbal niche structures.
Invest. Ophthalmol. Vis. Sci. 64 (8), 4026, 2023.

DEA WoS

9.

Rebenku, I., Lloyd, C. B., Szöllősi, J., Vereb, G.: Pixel-by-pixel autofluorescence corrected FRET in fluorescence microscopy improves accuracy for samples with spatially varied autofluorescence to signal ratio.
Sci. Rep. 13 (1), 1-15, (article identifier: 2934), 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

10.

Rebenku, I., Bartha, F., Katona, T., Zsebik, B., Antalffy, G., Takács, L., Molnár, B., Vereb, G.: Taking molecular pathology to the next level: whole slide multicolor confocal imaging with the Pannoramic Confocal digital pathology scanner.
Cytom. Part A. 103 (3), 198-207, 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Cell Biology

Q1 Histology

Q1 Pathology and Forensic Medicine

11.

Bankó, C., Nagy, Z. L., Nagy, M., Szemán-Nagy, G., Rebenku, I., Imre, L., Tiba, A., Hajdu, A., Szöllősi, J., Kéki, S., Bacsó, Z.: Isocyanide Substitution in Acridine Orange Shifts DNA Damage-Mediated Phototoxicity to Permeabilization of the Lysosomal Membrane in Cancer Cells.
Cancers (Basel). 13 (22), 1-24, (article identifier: 5652), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

12.

Csomós, I., Nagy, P., Filep, C. B., Rebenku, I., Nizsalóczki, E., Kovács, T., Vámosi, G., Mátyus, L., Dóczy-Bodnár, A.: Opposing Effects of Chelidonine on Tyrosine and Serine Phosphorylation of STAT3 in Human Uveal Melanoma Cells.
Int. J. Mol. Sci. 22 (23), 1-14, (article identifier: 12974), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

13.

Nemes, D., Kovács, R. L., Nagy, F., Tóth, Z., Herczegh, P., Borbás, A., Kelemen, V., Pfliegler, V. P., Rebenku, I., Hajdu, P., Fehér, P., Ujhelyi, Z., Fenyvesi, F., Váradi, J., Vecsernyés, M., Bácskay, I.: Comparative biocompatibility and antimicrobial studies of sorbic acid derivates.
Eur. J. Pharm. Sci. 143, 1-9, (article identifier: 105162), 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

14.

Hajdu, T., Váradi, T., Rebenku, I., Kovács, T., Szöllősi, J., Nagy, P.: Comprehensive Model for Epidermal Growth Factor Receptor Ligand Binding Involving Conformational States of the Extracellular and the Kinase Domains.
Front. Cell. Dev. Biol. 8, 1-53, 2020.

doi DEA

Journal metrics:

Q1 Cell Biology

Q1 Developmental Biology

15.

Nagy, F., Tóth, Z., Bozó, A., Czeglédi, A., Rebenku, I., Majoros, L., Kovács, R. L.: Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 57 (5), 573-581, 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Infectious Diseases

Q1 Medicine (miscellaneous)

D1 Veterinary (miscellaneous)

Rebenku István

Publication list